Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism

D Burger; I Heiden; C la Porte; M van den Ende; C Richter; P Koopmans; F Kroon; H Sprenger; Jan Lindemans; P (Paul) Schenk; R van Schaik; PHP Groeneveld

doi:10.1111/j.1365-2125.2005.02536.x

Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism

D Burger, I Heiden, C la Porte, M van den Ende, C Richter, P Koopmans, F Kroon, H Sprenger, Jan Lindemans, P (Paul) Schenk, R van Schaik, PHP Groeneveld

Research output: Contribution to journal › Article › Academic › peer-review

196 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	148-154
Number of pages	7
Journal	British Journal of Clinical Pharmacology
Volume	61
Issue number	2
DOIs	https://doi.org/10.1111/j.1365-2125.2005.02536.x
Publication status	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1365-2125.2005.02536.x

http://hdl.handle.net/1765/70399

Cite this

Burger, D., Heiden, I., la Porte, C., van den Ende, M., Richter, C., Koopmans, P., Kroon, F., Sprenger, H., Lindemans, J., Schenk, P., van Schaik, R., & Groeneveld, PHP. (2006). Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism. British Journal of Clinical Pharmacology, 61(2), 148-154. https://doi.org/10.1111/j.1365-2125.2005.02536.x

@article{7f3d50efb02d4989a9c3f048ccf0596a,

title = "Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism",

author = "D Burger and I Heiden and {la Porte}, C and {van den Ende}, M and C Richter and P Koopmans and F Kroon and H Sprenger and Jan Lindemans and Schenk, {P (Paul)} and {van Schaik}, R and PHP Groeneveld",

year = "2006",

doi = "10.1111/j.1365-2125.2005.02536.x",

language = "Undefined/Unknown",

volume = "61",

pages = "148--154",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "2",

}

Burger, D, Heiden, I, la Porte, C, van den Ende, M, Richter, C, Koopmans, P, Kroon, F, Sprenger, H, Lindemans, J, Schenk, P, van Schaik, R & Groeneveld, PHP 2006, 'Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism', British Journal of Clinical Pharmacology, vol. 61, no. 2, pp. 148-154. https://doi.org/10.1111/j.1365-2125.2005.02536.x

Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism. / Burger, D; Heiden, I; la Porte, C et al.
In: British Journal of Clinical Pharmacology, Vol. 61, No. 2, 2006, p. 148-154.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism

AU - Burger, D

AU - Heiden, I

AU - la Porte, C

AU - van den Ende, M

AU - Richter, C

AU - Koopmans, P

AU - Kroon, F

AU - Sprenger, H

AU - Lindemans, Jan

AU - Schenk, P (Paul)

AU - van Schaik, R

AU - Groeneveld, PHP

PY - 2006

Y1 - 2006

U2 - 10.1111/j.1365-2125.2005.02536.x

DO - 10.1111/j.1365-2125.2005.02536.x

M3 - Article

SN - 0306-5251

VL - 61

SP - 148

EP - 154

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

IS - 2

ER -